← Back to patent-cliff list
CAS 2109226-54-0
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Chain position details for this CAS are not yet recorded.
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications |
|---|---|---|---|---|---|
| Unibest Nantong cGMP Site | 3-Methyl-3-(methylsulfonyl)but-1-yne Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — |
Listed key intermediates
| Product / CAS | Purity / impurities | Capacity | Qualifications | Packing / cold chain | MOQ / price band | Action |
|---|---|---|---|---|---|---|
Lenacapavir INT-4｜3-甲基-3-(甲磺酰基)-1-丁炔 2109226-54-0 | ≥98.0% | 2,400 kg/年 | 25 kg 桶 | 5 kg · US$ 780-1,150 / kg |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.